ストックスクリーナーアプリを入手
5.57
2.77%
0.15
アフターアワーズ：
5.51
-0.06
-1.08%
Mannkind Corp (MNKD) 最新ニュース
Jacobs Levy Equity Management Inc. Has $10.21 Million Stake in MannKind Corporation $MNKD - MarketBeat
Millennium Management LLC Acquires 2,375,198 Shares of MannKind Corporation $MNKD - MarketBeat
MannKind Corporation $MNKD Shares Sold by Parkman Healthcare Partners LLC - MarketBeat
Analysts Set MannKind Corporation (NASDAQ:MNKD) Target Price at $10.71 - MarketBeat
MannKind Corporation $MNKD Shares Sold by Nitorum Capital L.P. - MarketBeat
PDT Partners LLC Acquires New Holdings in MannKind Corporation $MNKD - MarketBeat
MannKind at Morgan Stanley Conference: Strategic Diversification Unveiled - Investing.com
MannKind at H.C. Wainwright: Focus on Pipeline Progress By Investing.com - Investing.com South Africa
MannKind at H.C. Wainwright: Focus on Pipeline Progress - Investing.com
Northern Trust Corp Sells 77,985 Shares of MannKind Corporation $MNKD - MarketBeat
Can MannKind Corporation navigate macro headwindsTrade Exit Report & Verified Swing Trading Watchlist - Lancaster City Council
MannKind (MNKD): A Fresh Look at Valuation Following New United Therapeutics Deal Expansion - Yahoo Finance
MannKind (NASDAQ:MNKD) Price Target Raised to $10.00 - MarketBeat
MannKind (NASDAQ:MNKD) Shares Gap Up After Analyst Upgrade - MarketBeat
What to expect from MannKind Corporation in the next 30 days2025 Analyst Calls & AI Driven Stock Reports - Newser
MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline - MSN
MannKind Shares Soar to Over 8-Year Highs on United Therapeutics’ Tyvaso Revenue Surge: Retail Is Optimistic - MSN
MannKind Gets A Price Bump As Pipeline Progresses - Finimize
Can MannKind Corporation grow without external fundingJuly 2025 Review & Stock Market Timing Techniques - خودرو بانک
Can MannKind Corporation outperform in the next rallyJuly 2025 Fed Impact & Short-Term Trading Alerts - خودرو بانک
Can trapped investors hope for a rebound in MannKind CorporationWeekly Risk Summary & AI Enhanced Trading Signals - Newser
MannKind Corporation stock prediction for this weekMarket Risk Analysis & High Conviction Investment Ideas - Newser
What candlestick patterns are forming on MannKind CorporationWatch List & Free Verified High Yield Trade Plans - Newser
MannKind at Cantor Global Healthcare Conference: Strategic Growth Insights - Investing.com
Has MannKind Corporation formed a bullish divergenceJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - Newser
Published on: 2025-09-04 00:37:09 - Newser
Will MannKind Corporation outperform small cap indexesJuly 2025 PostEarnings & Capital Efficient Trading Techniques - خودرو بانک
MannKind at Wells Fargo Conference: Strategic Diversification Unveiled - Investing.com
MannKind Corporation recovery potential after sell offTrade Exit Summary & Community Consensus Trade Signals - Newser
MannKind stock price target raised to $11 by H.C. Wainwright on Tyvaso success - Investing.com
MannKind (MNKD) Expands United Therapeutics Deal Can New Platform Revenues Transform Its Long-Term Story? - simplywall.st
MannKind Corporation (NASDAQ:MNKD) Looks Just Right With A 53% Price Jump - simplywall.st
Can MannKind Corporation recover in the next quarterWeekly Market Outlook & Accurate Technical Buy Alerts - Newser
Mannkind Corporation shares rise 1.22% premarket after United Therapeutics' drug Tyvaso shows significant lung function improvement. - AInvest
Published on: 2025-09-03 02:55:27 - Newser
Forecasting MannKind Corporation price range with options dataIPO Watch & Weekly Watchlist for Hot Stocks - Newser
Combining machine learning predictions for MannKind CorporationJuly 2025 Recap & Safe Capital Investment Plans - Newser
Can MannKind Corporation ride the EV waveShare Buyback & Target Return Focused Picks - خودرو بانک
Trend analysis for MannKind Corporation this weekMarket Activity Report & Real-Time Volume Spike Alerts - Newser
Does MannKind Corporation show high probability of reboundJuly 2025 Breakouts & Real-Time Market Trend Scan - Newser
Historical volatility pattern of MannKind Corporation visualized2025 Market Overview & Smart Allocation Stock Reports - Newser
MannKind Lands A Price-Target Hike After Partner United Therapeutics Reports Strong Lung Drug Trial Results - Stocktwits
Is MannKind Corporation stock a buy or sellQuarterly Performance Summary & Low Drawdown Momentum Ideas - خودرو بانک
Leerink Partners Reiterates a Buy Rating on MannKind Corporation (MNKD), Keeps the PT at $7 - MSN
Applying chart zones and confluence areas to MannKind CorporationPortfolio Growth Summary & Weekly Sector Rotation Insights - Newser
What MACD and RSI say about MannKind CorporationMarket Sentiment Review & Verified Momentum Watchlists - Newser
Mannkind (MNKD) Surges 25% on Strategic Acquisition and Financing Hints – What’s Next? - AInvest
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):